Clinical Trial Update: Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating cediranib maleate and selumetinib sulfate in patients with solid malignancies, including metastatic melanoma; the study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Melanoma

Drugs mentioned

• Cediranib Maleate (cediranib)
• Selumetinib Sulfate (selumetinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Melanoma, Refractory Malignant Solid Neoplasm | Phase 1 | Status: ACTIVE_NOT_RECRUITING